We plan to extend our previous studies on mechanisms underlying regulation of OigARs, by investigating the scaffolding protein spinophilin in aiaAR signaling/ trafficking. Preliminary data demonstrate spinophilin interacts with aiaARs witfi higher affinity than ait>ARs We also plan to extend our studies by studying matnx metalloproteases (MMPs) in mediating aiaAR signaling via EGFR transactivation compared with aibARs. Here we have a powerful new tool, a.naturally occurnng human 3"* intracellular loop aia-SNP G247R, which in our preliminary data provides differential activation of specific MMP subtypes Finally, while aims 1 &2 explore targeted, clinically relevant signaling proteins/ pathways, we recognize the importance of exploring novel binding partners Therefore our last specific aim will use Tandem-Affinity Purification combined with mass spectrometry to identify novel multi-protein complexes (the broader OiaAR signalosome) important in OiaAR signaling/ trafficking.- Unique resources and collaborators available at the Univ of WA make this approach both feasible and quantitative.
AIM 1 : Targeted examination ofthe scaffold protein spinophilin in aiaAR signaling and trafficking Hypothesis. Spinophilin binding to the OigAR 3^ loop mediates distinct subtype signalingArafficking 1 a Characterize spinophilin/oiaAR 3^*^ loop binding (co-immunoprecipitation assays, structure/function - analysisryeast 2-hybrid effects) &altered signaling pathways-(specific inhibitors,-siRNAs) ? -? 1 b Examine role of spinophilin in OiaAR constitutive &agonist-induced trafficking , 1 c. Compare OiaAR sphinophilin-modulated signaling effects with OibAR and OiaAR 3"* loop SNP G247R AIIM 2: Investigate role of IMMPs in EGFR transactivation in aiaAR signaling Hypothesis: Differential activation of specific MMPs by aiAR subtypes mediates distinct signalingArafTicking 2 a Characterize role of MMPs in EGFR transactivation for differential OiaAR signaling (WT vs G247SNP) 2 b Examine gene expression arrays for OigAR WT ve'rsus G247 SNP &aib to identify specific MMPs involved (confirm using specific transactivation assays and inhibitors) AIM 3'Utilize genomic/proteomic approaches to identify broader aiaAR signalosome Hypothesis. Proteomics can be used to identify novel proteins in broader multi-protein complexes (signalosome) important in unique aigAR signaling and cellular trafficking 3.a Create tandem-affinity purification (TAP)-tag constructs for OigAR, OibAR Oia-SNP, establish cell lines 3.b Use proteomics-tandem reverse-phase liquid chromatography mass spectrometry (LC-MS/MS, LTQ- FT) technology to identify multi-protein complexes important in aia versus OibAR signaling/trafficking 3 c Perturb system (agonist/antagonist drugs, G247R Oi^-SNP) to identify differential signalosomes' 3 d Compare OiaAR signalosomes in 4 cell lines commonly used in OigAR studies (rat/human with different . surface versus intracellular receptor expression to identify key proteins modulating OiaAR trafficking

Public Health Relevance

' QiaARs are important in many diseases such as hypertension, blood vessel repair, prostate and myocardial hypertrophy, and myocardial ischemia Understanding how these receptors are regulated, particularly in their unique cellular environments, provides new understanding and drug targets for disease treatment

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL049103-19
Application #
8259173
Study Section
Special Emphasis Panel (NSS)
Program Officer
Wong, Renee P
Project Start
1993-09-01
Project End
2012-10-31
Budget Start
2012-05-01
Budget End
2012-10-31
Support Year
19
Fiscal Year
2012
Total Cost
$430,508
Indirect Cost
$171,166
Name
University of Washington
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Kleine-Brueggeney, Maren; Gradinaru, Irina; Babaeva, Ekaterina et al. (2014) Alpha1a-adrenoceptor genetic variant induces cardiomyoblast-to-fibroblast-like cell transition via distinct signaling pathways. Cell Signal 26:1985-97
Lei, Beilei; Schwinn, Debra A; Morris, Daniel P (2013) Stimulation of *1a adrenergic receptors induces cellular proliferation or antiproliferative hypertrophy dependent solely on agonist concentration. PLoS One 8:e72430
Landau, Ruth; Schwinn, Debra (2013) Genotyping without phenotyping: does it really matter? Anesth Analg 116:8-10
Schwinn, D A (2011) Genetics and patient outcome after cardiac surgery: unravelling translational findings. Br J Anaesth 107:839-41
von Homeyer, Peter; Schwinn, Debra A (2011) Pharmacogenomics of ?-adrenergic receptor physiology and response to ?-blockade. Anesth Analg 113:1305-18
Oganesian, Anush; Yarov-Yarovoy, Vladimir; Parks, William C et al. (2011) Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway. Proc Natl Acad Sci U S A 108:19796-801
Lei, Beilei; Morris, Daniel P; Smith, Michael P et al. (2009) Lipid rafts constrain basal alpha(1A)-adrenergic receptor signaling by maintaining receptor in an inactive conformation. Cell Signal 21:1532-9
Turer, Aslan T; Schwinn, Debra A (2008) Understanding the transition to acute illness: the promise of perioperative genomics. J Cardiovasc Transl Res 1:171-3
Morris, Daniel P; Lei, Beilei; Wu, Yue-Xuan et al. (2008) The alpha1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits. J Biol Chem 283:2973-85
Stafford-Smith, Mark; Bartz, Raquel; Wilson, Katrina et al. (2007) Alpha-adrenergic mRNA subtype expression in the human nasal turbinate. Can J Anaesth 54:549-55

Showing the most recent 10 out of 35 publications